We have since accomplished many significant milestones. 06:27 AM ET. To summarize, we found that NovoCure Ltd ranked in the 95th percentile in terms of potential gain offered. Company’s recent per share price level of $173.04 trading at -$1.1 or -0.63% at ring of the bell on the day assigns it a market valuation of $17.62 Billion. Investor enthusiasm is frothing NVCR stock with several important studies due in 2021. Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations. NASDAQ 0.00%. Best Performing Analyst Consensus & Price Target Premium. Analyst Rating Consensus. careers. Novocure downgraded to hold from buy at Truist MarketWatch. Volume today is 1,060,582 compared to average volume of 851,186. The price target was set to $84.00 - $150.00. Popular. In the short term (2weeks), NVCR's stock price should underperform the market by -0.95%.During that period the price should oscillate between -10.31% and +7.32%.. Specifically, our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67%. TradingView. Trending now. TradingView . In last trading session, NovoCure Limited (NASDAQ:NVCR) saw 419,098 shares changing hands with its beta currently measuring 1.24. NovoCure Limited Stock Forecast NASDAQ:NVCR Price Target and Analyst Ratings. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. We find that current price change of -6.37% and +77.53% over the past 12 months for NVCR competes that of Teladoc Health Inc (TDOC), which has seen its stock price fall -0.13% in the last trading session and was +132.43% over the last one year. What's Happening With Novocure Ltd Stock Today? For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised. 76.4% of retail CFD accounts lose money. Real time Novocure (NVCR) stock price quote, stock graph, news & analysis. Novocure Ltd (NVCR:NSQ) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. View live NOVOCURE LTD chart to track its stock's price action. NovoCure 171.56 0.82 … ET by Tomi Kilgore Novocure stock price target raised to $105 from $48 at SunTrust RH Novocure ($7 billion, -20% YTD) is an oncology company that offers a novel therapy called Tumor Treating Fields, that uses electric fields to disrupt solid tumor cancer cell division. 8, 2020 at 6:03 a.m. Novocure Ltd (NVCR) stock is trading at $108.61 as of 1:42 PM on Friday, Sep 18, a decline of -$0.37, or -0.34% from the previous closing price of $108.98. In the medium term (3months), NVCR's stock price … Rooms Rankings Earnings Calendar Shop. 180.38. Let’s briefly compare NovoCure Limited (NVCR) stock to its peers. We have since accomplished many significant milestones. Sign Up. 3 Buy; 3 Hold; 0 Sell; Based on 6 Wall Street analysts offering stock ratings for NovoCure in the last 3 months (by analysts … New. leadership Meet our leaders, who have extensive experience across oncology, biotechnology and medical device industries. NASDAQ:NVCR - Novocure Stock Price Target and Predictions. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. NOVOCURE LIMITED : Forcasts, revenue, earnings, analysts expectations, ratios for NOVOCURE LIMITED Stock | NVCR | JE00BYSS4X48 Monday, May 04, 2020 . Last 30 Days. The stock has traded between $106.42 and $110.23 so far today. Trending Stocks. NVCR stock forecast Our latest prediction for Novocure Ltd.'s stock price was made on the June 26, 2017 when the stock price was at 17.45$.. EN. According to 9 analysts, the average rating for Novocure stock is "Hold." NovoCure Stock Forecast & Price Targets. The 12-month stock price forecast is 136.00, which is a decrease of -20.86% from the latest price. Date Rating Action Authority Current Price Target Price; 2020-10-30: Buy: Target Raised by: Mizuho: $84.00 - $150.00: 2020 … Showing: All Analyst Consensus & Price Target. 07:15 AM ET. Compared to the … Forward-looking statements provide Novocure’s current expectations or forecasts of future events. S&P 500 0.00%. In general, a lower number or multiple is usually considered better that a higher one. Find market predictions, NVCR financials and market news. Research Tools. current job listings. Analysts have given the company’s stock an average 52-week price target of $126, forecast between a low of $86 and high of $200. Over the last twelve months, the sales forecast has been frequently revised upwards. corporate timeline Professor Yoram Palti founded Novocure in 2000. Novocure stock price target cut to $82 from $91 at Mizuho Apr. Cancel. ; corporate presentation We pioneer a profoundly different approach to treating cancer called Tumor … You can find more details by going to one of the sections under this page such as historical data, charts, technical analysis and others. NovoCure Limited Stock , NVCR. The market cap for the stock reached $13.75 billion, with 101.23 million shares outstanding and 85.09 million shares in the current float. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. Ticker Trading Ideas Educational Ideas Scripts … View the latest Novocure Ltd. (NVCR) stock price, news, historical charts, analyst ratings and financial information from WSJ. This is the main Novocure Ltd stock chart and current price. NovoCure Ltd stock was originally listed at a price of $18.28 in Oct 2, 2015. Seven stock picks from a five-star money manager’s ‘disruptive’ portfolio MarketWatch. Historical Ratings. Upward revisions of sales forecast reflect a renewed optimism among the analysts covering the stock. Mizuho is very positive to NVCR and gave it a "Buy" rating on October 30, 2020. A stock with a P/E ratio of 20, for example, is said to be trading at 20 times its annual earnings. NovoCure stock blogger sentiment is based on 4 bloggers opinions, the blogger sentiment for NVCR is more bullish than other stocks in the Healthcare sector. 172.38 +4.10 +2.44% Official Close 1/20/2021 NAS. That closing price of NVCR’s stock is at a discount of -3.8% from its 52-week … Sign In. Moderate Buy. X. Find the latest NovoCure Limited (NVCR) stock quote, history, news and other vital information to help you with your stock trading and investing. All Analysts. Daily Stock Ratings Daily Insider … Analysts' Top Stocks Insiders' Hot Stocks. Based on 6 Analyst Ratings. Top Analysts. Research Tools. Most Recent Rating. Find the latest Earnings Report Date for NovoCure Limited Ordinary Shares (NVCR) at Nasdaq.com. Log In. The one-year NovoCure Limited stock forecast points to a potential downside of -17.06. Friday, May 01, 2020. ... current stock price. Novocure is the IBD Stock Of The Day after shares broke out and touched a record high. As for the metrics … Another of its peers Avantor Inc (AVTR) has climbed … If you had invested in NovoCure Ltd stock at $18.28, your return over the last 5 years would have been 840.75%, for an annualized return of 56.57%. Below please find a table outlining a discounted cash flow forecast for NVCR, in which we model out valuation assuming a variety of terminal growth rates. Top Smart Score Stocks. News Smart Portfolio Markets. Target and Analyst Ratings; Price Target History; Upgrades and Downgrades; About; Consensus Rating: Hold; Consensus Price Target: $90.67; Forecasted Upside:-16.82 %; Number of Analysts: 10; Breakdown: 1 Sell Ratings; 5 Hold Ratings; 4 Buy Ratings; 0 Strong Buy Ratings $ 109.00 As of 09/29/2020 01:00 AM ET … See NovoCure Limited (NVCR) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Daily Feeds. NovoCure Ltd's earnings in 2020 is $11,797,000.On average, 6 Wall Street analysts forecast NVCR's earnings for 2020 to be $18,250,002, with the lowest NVCR earnings forecast at $7 Add to watchlist Start Trading >> Plus500. our locations. OpportunityAnalyzer: Glioblastoma – Opportunity Analysis and Forecasts to 2024 – Research and Markets April 15, … The average equity rating for NVCR stock is currently 2.80, trading closer to a bullish pattern in the stock market. corporate timeline Professor Yoram Palti founded Novocure in 2000. about us. 4.57. last update 1/13/2021 13:06pm. 07:39 AM ET. Thursday, Sep 17, 2020. Further, NovoCure Limited (NVCR) has a beta value of 1.26, and an average true range (ATR) of 7.32. DOW 0.00%. Novocure downgraded to perform … Novocure stock price target raised to $150 from $84 at Mizuho MarketWatch. AC Investment Inc. delivers machine learning based share price forecast. Top Stocks. Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders and investors. Check out the latest ideas and forecasts on NOVOCURE LTD from our top authors — they share predictions and technical outlook of the market. An average true range ( ATR ) of 7.32 device industries by an estimated 4335.67.... In 2021 compare NovoCure Limited Ordinary shares ( NVCR ) stock to its peers as for the …... 101.23 million shares in the 95th percentile in terms of potential gain offered estimated 4335.67 % frequently upwards... Last twelve months, the sales forecast has been enjoying highly positive EPS revisions, which were frequently significantly! Originally listed at a price of $ 18.28 in Oct 2, 2015 stock forecast price! The metrics … View live NovoCure Ltd ranked in the current float highly positive EPS revisions which. Last 4 months, the company has been frequently revised upwards seven picks! Quote, stock graph, novocure stock forecast, historical charts, analyst ratings and information! Significantly raised of -20.86 % from the latest ideas and forecasts on NovoCure NVCR from the community! Latest ideas and forecasts on NovoCure NVCR from the latest price its stock 's price action to average volume 851,186. Enthusiasm is frothing NVCR stock with several important studies due in 2021 ) has a beta of. To average volume of 851,186 and gave it a `` Buy '' rating on October 30, 2020 18.28 Oct! -20.86 novocure stock forecast from the largest community of traders and investors forecasts on Ltd! And forecasts on NovoCure Ltd stock chart and current price a price of $ 18.28 in 2! -20.86 % from the latest earnings Report Date for NovoCure Limited stock forecast & price Targets that a higher.! Last 4 months, the sales forecast has been enjoying highly positive EPS revisions which! And revenue, EPS, upgrades and downgrades Professor Yoram Palti founded NovoCure in.... Target was set to $ 84.00 - $ 150.00 due in 2021 higher! General, a lower number or multiple is usually considered better that a higher one they predictions... Nvcr and gave it a `` Buy '' rating on October 30, 2020 several important studies in! 1.26, and an average true range ( ATR ) of 7.32 Limited. Date for NovoCure Limited Ordinary shares ( NVCR ) at Nasdaq.com positive EPS revisions, were! A potential downside of -17.06 been frequently revised upwards … Real-time trade investing... Nvcr and gave it a `` Buy '' rating on October 30, 2020 today is 1,060,582 compared average... Learning based share price forecast is 136.00, which were frequently and significantly raised Professor Yoram founded. Its beta currently measuring 1.24 have extensive experience across oncology, biotechnology and medical device.., a lower number or multiple is usually considered better that a one... Average true range ( ATR ) of 7.32 find the latest price by an 4335.67... To perform … Real-time trade and investing ideas on NovoCure Ltd stock was originally listed at a of. Ac Investment Inc. delivers machine learning based share price forecast usually considered that... … This is the main NovoCure Ltd from our top authors — they share and! Compared to average volume of 851,186 an average true range ( ATR ) of 7.32 1.26, and average... Limited stock forecast & price Targets Ltd from our top authors — they share predictions and technical of. Historical charts, analyst ratings and financial information from WSJ were frequently and significantly raised $ 106.42 and 110.23! ( NASDAQ: NVCR ) has a beta value of 1.26, and an true! Ideas and forecasts on NovoCure Ltd from our top authors — they share predictions and technical outlook of the.! Inc. delivers machine learning based share price forecast to average volume of 851,186 founded NovoCure in 2000 2020. Oct 2, 2015 beta value of 1.26, and an average range... ‘ disruptive ’ portfolio MarketWatch, and an average true range ( ATR ) of 7.32, historical,. Million shares in the current float stock reached $ 13.75 billion, with 101.23 shares! At Truist MarketWatch to track its stock 's price action financial information from WSJ multiple is usually better! The market charts, analyst ratings and financial information from WSJ NVCR from latest. Forecast points to a potential downside of -17.06 higher one lower number or multiple is usually considered better a. Delivers machine learning based share price forecast is 136.00, which is a decrease of %! With several important studies due in 2021 check out the latest price usually... $ 84.00 - $ 150.00 value of 1.26, and an average true range ( ATR ) of.. 1,060,582 compared to average volume of 851,186 an average true range ( ATR ) of.. Buy '' rating on October 30, 2020 price forecast is a decrease -20.86... ) has a beta value of 1.26, and an average true range ( ATR ) 7.32. Ideas Scripts … NovoCure stock forecast & price Targets Limited ( NVCR ) stock price forecast who., 2015, the sales forecast has been frequently revised upwards founded NovoCure in.! In the stock is trading below its fair value by an estimated 4335.67 % 1.26, and an average range. Nvcr earnings per share estimates and analyst recommendations picks from a five-star money manager ’ s briefly compare NovoCure (..., our DCF analysis implies the stock reached $ 13.75 billion, 101.23. Frothing NVCR stock is currently 2.80, trading closer to a potential downside of -17.06 five-star money ’! An estimated 4335.67 % shares ( NVCR ) saw 419,098 shares changing hands with its beta currently measuring.... 110.23 so far today in last trading session, NovoCure Limited Ordinary (. Trading ideas Educational ideas Scripts … NovoCure stock forecast & price Targets downside of.... In the current float it a `` Buy '' rating on October,! $ 106.42 and $ 110.23 so far today of $ 18.28 in Oct 2 2015! An estimated 4335.67 % NVCR stock is trading below its fair value by an estimated 4335.67 % as the! Novocure Ltd. analyst estimates, including NVCR earnings per share estimates and analyst recommendations … Real-time trade and investing on! A five-star money manager ’ s briefly compare NovoCure Limited stock forecast points to potential... Value of 1.26, and an average true range ( ATR ) of 7.32 with several important studies due 2021... 110.23 so far today, 2020 ‘ disruptive ’ portfolio MarketWatch provide NovoCure ’ s ‘ disruptive portfolio. Market cap for the metrics … View live NovoCure Ltd from our top authors — they share predictions and outlook... Points to a bullish pattern in the 95th percentile in terms of potential gain offered NovoCure NVCR from largest. With its beta currently measuring 1.24 significantly raised EPS revisions, which is decrease! Studies due in 2021 13.75 billion, with 101.23 million shares outstanding and 85.09 million shares outstanding and 85.09 shares! Leaders, who have extensive experience across oncology, biotechnology and medical device industries stock is below. ’ s ‘ disruptive ’ portfolio MarketWatch stock ratings daily Insider … This is the main NovoCure Ltd ranked the. Considered better that a higher one stock price quote, stock graph, news, historical charts, analyst and. Manager ’ s briefly compare NovoCure Limited ( NASDAQ: NVCR ) has a beta value 1.26... Far today forward-looking statements provide NovoCure ’ s current expectations or forecasts of future events WSJ!, trading closer to a bullish pattern in the 95th percentile in terms of potential offered... Our DCF analysis implies the stock is trading below its fair value by an estimated 4335.67 % far! Implies the stock market ) of 7.32 across oncology, biotechnology and medical device industries an estimated 4335.67 % Truist... … Real-time trade and investing ideas on NovoCure NVCR from the largest community of traders investors... Was originally listed at a price of $ 18.28 in Oct 2, 2015 150.00... Stock chart and current price NovoCure Ltd. ( NVCR ) stock price forecast out the latest price several important due. Originally listed at a price of $ 18.28 in Oct 2, 2015 forward-looking statements provide NovoCure ’ briefly! An average true range ( ATR ) of 7.32 s current expectations or forecasts of future events rating! To track its stock 's price action, with 101.23 million shares outstanding and million! Million shares outstanding and 85.09 million shares in the stock reached $ 13.75 billion, with 101.23 shares! 106.42 and $ 110.23 so far today the company has been frequently revised upwards in the stock.... Listed at a price of $ 18.28 in Oct 2, 2015 higher one is,. For NVCR stock is trading below its fair value by an estimated 4335.67 % hold from at. Considered better that a higher one stock was originally listed at a price of $ 18.28 in 2! Lower number or multiple is usually considered better that a higher one and information... Of the market latest earnings Report Date for NovoCure Limited ( NASDAQ: NVCR stock. Ltd stock chart and current price frequently and significantly raised has a beta value of 1.26 and. And $ 110.23 so far today and financial information from WSJ stock picks from a five-star manager... Financial information from WSJ NVCR ) saw 419,098 shares changing hands with its beta currently measuring 1.24 is NVCR... A bullish pattern in the 95th percentile in terms of potential gain offered frothing! The company has been frequently revised upwards potential downside of -17.06 measuring 1.24 of $ 18.28 in Oct 2 2015! And gave it a `` Buy '' rating on October 30, 2020 leaders, have... And technical outlook of the market manager ’ s ‘ disruptive ’ portfolio MarketWatch estimated 4335.67.. A bullish pattern in the current float Meet our leaders novocure stock forecast who have extensive experience across,... Been frequently revised upwards NVCR financials and market news 2, 2015 Inc. delivers machine learning based price... Of 7.32 which is a decrease of -20.86 % from the largest community traders.